Bulk Paclitaxel Strategic Industry Report 2024: Rising Global Cancer Incidence Throws the Spotlight on Paclitaxel Demand - Forecasts to 2030
02 août 2024 05h07 HE
|
Research and Markets
Dublin, Aug. 02, 2024 (GLOBE NEWSWIRE) -- The "Bulk Paclitaxel - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Bulk Paclitaxel...
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
29 juil. 2024 09h15 HE
|
AIM ImmunoTech Inc.
OCALA, Fla., July 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the next CEO Corner segment has been published on the Company’s...
Triple Negative Breast Cancer Market Analysis and Insights Reveal Dynamic Shifts and Future Growth Projections to 2032
24 janv. 2024 10h36 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's...
Occlusion Perfusion Catheter Demonstrates Superior Performance in PAD Drug Delivery
02 nov. 2023 08h28 HE
|
Advanced Catheter Therapies
Researchers successfully demonstrate the delivery of liquid sirolimus into the arterial wall using the OPC, which can also be used for paclitaxel BTK.
[Latest] Global Paclitaxel Injection Market Size/Share Worth USD 11.4 Billion by 2030 at a 13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
30 mai 2023 06h30 HE
|
Custom Market Insights
Austin, TX, USA, May 30, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Paclitaxel Injection Market Size, Share, Growth Analysis Report By Indication...
Global Ovarian Cancer Drugs Market Report 2023: Major Players Include AstraZeneca, Roche, Tesaro, Clovis Oncology and Amgen
14 avr. 2023 10h28 HE
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Global Ovarian Cancer Drugs Market Analysis, Trends, Opportunity, and Forecasts 2017-2022 & 2023-2027: Growing Prevalence of Ovarian Cancer and Increasing R&D Activities in Development
19 janv. 2023 05h43 HE
|
Research and Markets
Dublin, Jan. 19, 2023 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By...
AIM ImmunoTech Announces Presentation of New Data from Roswell Park Comprehensive Cancer Center Evaluating Ampligen® as a Component of a Chemokine-Modulating (CKM) Regimen, with Paclitaxel, for the Treatment of Early-Stage Triple Negative Breast Cancer
14 nov. 2022 07h00 HE
|
AIM ImmunoTech Inc.
– Data selected for poster presentation at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting – Treatment was well tolerated, with promising clinical activity of pathologic complete...
Drug-eluting Balloon Catheters Market to hit USD 1 billion by 2030, says Global Market Insights Inc.
07 nov. 2022 08h10 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The global drug-eluting balloon catheters market value is poised to surpass USD 1 billion by 2030, according to a new research report by...
Drug-Eluting Balloon Catheters Market to hit USD 916 Million by 2028, Says Global Market Insights Inc.
13 avr. 2022 07h15 HE
|
Global Market Insights Inc.
Selbyville, Delaware, April 13, 2022 (GLOBE NEWSWIRE) -- Global drug-eluting balloon catheters market value is anticipated to reach USD 916 million by 2028, according to a new research report by...